Company · CIK 1679628
JUPITER NEUROSCIENCES, INC.
| CIK | 1679628 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | FL |
| Listed | JUNS (Nasdaq) |
| First annual or quarterly report | 2024-12-23 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-299124 | 2026-09-25 | 2026-09-25 | 1 | |
| 333-295085 | 2026-04-16 | 2026-08-24 | 4 | |
| 333-297073 | 2026-06-26 | 2026-07-07 | 2 | |
| 333-291832 | 2025-11-26 | 2025-12-11 | 2 | |
| 333-260183 | 2021-10-12 | 2024-12-02 | 25 |
Filings
35| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-25 | S-3Shelf registered | 333-299124 | 0001493152-26-044210 |
| 2026-08-24 | 424B5Shelf takedown | 333-295085 | 0001493152-26-039784 |
| 2026-07-07 | EFFECTDeclared effective | 333-297073 | 9999999995-26-002213 |
| 2026-06-26 | S-1Registration filed | 333-297073 | 0001493152-26-030312 |
| 2026-05-21 | 424B5Shelf takedown | 333-295085 | 0001493152-26-024740 |
| 2026-04-24 | EFFECTDeclared effective | 333-295085 | 9999999995-26-001329 |
| 2026-04-16 | S-3Shelf registered | 333-295085 | 0001493152-26-016935 |
| 2025-12-11 | EFFECTDeclared effective | 333-291832 | 9999999995-25-003679 |
| 2025-11-26 | S-1Registration filed | 333-291832 | 0001493152-25-025204 |
| 2024-12-02 | 424B4Final prospectus | 333-260183 | 0001493152-24-048318 |
| 2024-11-08 | EFFECTDeclared effective | 333-260183 | 9999999995-24-003407 |
| 2024-10-18 | S-1/AAmendment | 333-260183 | 0001493152-24-041537 |
| 2024-09-13 | S-1/AAmendment | 333-260183 | 0001493152-24-036247 |
| 2024-09-04 | S-1/AAmendment | 333-260183 | 0001493152-24-035002 |
| 2024-09-04 | S-1/AAmendment | 333-260183 | 0001493152-24-034903 |
| 2024-07-12 | S-1/AAmendment | 333-260183 | 0001493152-24-027145 |
| 2023-01-17 | S-1/AAmendment | 333-260183 | 0001493152-23-001540 |
| 2023-01-06 | S-1/AAmendment | 333-260183 | 0001493152-23-000795 |
| 2022-12-07 | S-1/AAmendment | 333-260183 | 0001493152-22-034670 |
| 2022-12-02 | S-1/AAmendment | 333-260183 | 0001493152-22-034319 |
| 2022-08-26 | S-1/AAmendment | 333-260183 | 0001493152-22-024119 |
| 2022-08-16 | S-1/AAmendment | 333-260183 | 0001493152-22-023233 |
| 2022-05-18 | S-1/AAmendment | 333-260183 | 0001493152-22-014343 |
| 2022-05-05 | S-1/AAmendment | 333-260183 | 0001493152-22-012197 |
| 2022-05-04 | S-1/AAmendment | 333-260183 | 0001493152-22-012044 |
| 2022-04-26 | S-1/AAmendment | 333-260183 | 0001493152-22-011151 |
| 2022-02-03 | S-1/AAmendment | 333-260183 | 0001493152-22-003091 |
| 2022-02-03 | S-1/AAmendment | 333-260183 | 0001493152-22-003042 |
| 2022-01-26 | S-1/AAmendment | 333-260183 | 0001493152-22-002313 |
| 2022-01-05 | S-1/AAmendment | 333-260183 | 0001493152-22-000453 |
| 2021-12-23 | S-1/AAmendment | 333-260183 | 0001493152-21-032436 |
| 2021-12-17 | S-1/AAmendment | 333-260183 | 0001493152-21-031850 |
| 2021-11-09 | S-1/AAmendment | 333-260183 | 0001493152-21-027617 |
| 2021-10-12 | S-1Registration filed | 333-260183 | 0001493152-21-025154 |
| 2021-10-01 | DRSDraft made public | 377-05552 | 0001493152-21-024318 |